Literature DB >> 12638721

Self image and quality of life in acromegaly.

Paola Pantanetti1, Nicoletta Sonino, Giorgio Arnaldi, Marco Boscaro.   

Abstract

Chronic effects of excessive GH secretion are not only disabling but also disfiguring. Most acromegalic patients present with 4-10 years history of changes in features, bony overgrowth, soft tissue swelling, skin changes, diabetes mellitus, hypertension and other cardiovascular symptoms. In addition to sign and symptoms of GH excess the patients demonstrate a loss initiative and spontaneity, mood swings, an impairments in self esteem, body image distortion, disruption in interpersonal relations and social withdrawal anxiety. Little research is available on the psychological features of acromegaly, despite their importance in this chronic and debilitating condition. Extremely little, however has appeared in the medical and psychological literature about mental and emotional disfunction in patients with acromegaly.

Entities:  

Mesh:

Year:  2002        PMID: 12638721     DOI: 10.1023/a:1022145116901

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  23 in total

1.  Slow-release lanreotide treatment in acromegaly: effects on quality of life.

Authors:  N Sonino; E Scarpa; A Paoletta; F Fallo; M Boscaro
Journal:  Psychother Psychosom       Date:  1999       Impact factor: 17.659

Review 2.  Acromegaly. Diagnosis and therapy.

Authors:  A L Barkan
Journal:  Endocrinol Metab Clin North Am       Date:  1989-06       Impact factor: 4.741

3.  Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.

Authors:  B A Bengtsson; S Edén; I Ernest; A Odén; B Sjögren
Journal:  Acta Med Scand       Date:  1988

4.  Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.

Authors:  Ulla Feldt-Rasmussen; Roger Abs; Bengt-Ake Bengtsson; Helge Bennmarker; Margareta Bramnert; Elizabeth Hernberg-Ståhl; John P Monson; Björn Westberg; Patrick Wilton; Christian Wüster
Journal:  Eur J Endocrinol       Date:  2002-01       Impact factor: 6.664

Review 5.  Psychological aspects of endocrine disease.

Authors:  N Sonino; G A Fava
Journal:  Clin Endocrinol (Oxf)       Date:  1998-07       Impact factor: 3.478

Review 6.  Acromegaly.

Authors:  S Melmed
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

Review 7.  The processing-speed theory of adult age differences in cognition.

Authors:  T A Salthouse
Journal:  Psychol Rev       Date:  1996-07       Impact factor: 8.934

8.  Psychosocial aspects of disease.

Authors:  Z J Lipowski
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

9.  The "quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism?

Authors:  A L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

10.  Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency.

Authors:  H B Baum; L Katznelson; J C Sherman; B M Biller; D L Hayden; D A Schoenfeld; K E Cannistraro; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

View more
  18 in total

1.  Biochemical and quality of life responses to octreotide-LAR in acromegaly.

Authors:  Ruth Mangupli; Paul Camperos; Susan M Webb
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

2.  Oro-dental pathologies in acromegaly.

Authors:  Ilonka Kreitschmann-Andermahr; Johannes Kohlmann; Bernadette Kleist; Ursula Hirschfelder; Rolf Buslei; Michael Buchfelder; Sonja Siegel
Journal:  Endocrine       Date:  2018-03-08       Impact factor: 3.633

3.  Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL.

Authors:  S Cannavò; R Condurso; M Ragonese; F Ferraù; A Alibrandi; I Aricò; G Romanello; S Squadrito; F Trimarchi; R Silvestri
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

4.  Assessment of balance performance and fear of falling in acromegalic patients: a comparative study.

Authors:  A Atmaca; B Tander; E K Kan; Y Ulus; G C Ecemis; Y Akyol; L Tomak
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

5.  Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly.

Authors:  S H P P Roerink; M A E M Wagenmakers; J F Wessels; R B T M Sterenborg; J W Smit; A R M M Hermus; R T Netea-Maier
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

6.  Quality of life in female patients with acromegaly.

Authors:  O Celik; P Kadioglu
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

7.  Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly.

Authors:  Tamara Wexler; Lindsay Gunnell; Zehra Omer; Karen Kuhlthau; Catherine Beauregard; Gwenda Graham; Andrea L Utz; Beverly Biller; Lisa Nachtigall; Jay Loeffler; Brooke Swearingen; Anne Klibanski; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

Review 8.  Left to themselves: Time to target chronic pain in childhood rare diseases.

Authors:  Christine B Sieberg; Alyssa Lebel; Erin Silliman; Scott Holmes; David Borsook; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2021-03-24       Impact factor: 8.989

9.  Effects of growth hormone receptor antagonism and somatostatin analog administration on quality of life in acromegaly.

Authors:  Laura E Dichtel; Allison Kimball; Kevin C J Yuen; Whitney Woodmansee; Melanie S Haines; Qiu Xia Guan; Brooke Swearingen; Lisa B Nachtigall; Nicholas A Tritos; Julie L Sharpless; Ursula B Kaiser; Anu V Gerweck; Karen K Miller
Journal:  Clin Endocrinol (Oxf)       Date:  2020-09-11       Impact factor: 3.523

10.  Acromegaly Quality of Life Questionnaire (AcroQoL).

Authors:  Xavier Badia; Susan M Webb; Luis Prieto; Nuria Lara
Journal:  Health Qual Life Outcomes       Date:  2004-02-27       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.